ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995